Care Atlas

CMS Open Payments · 2024

Dr. Jeffrey Dugas

Orthopaedic Surgery · BIRMINGHAM, AL · NPI 1912974734

Many doctors share a name — check the specialty and city above match your doctor before you read this as theirs.

$2,818,351 reported by drug & device companies in 2024 · 49 payments

Not all payments mean the same thing. Split apart:

$36,412
Promotional

Meals, speaking fees, travel, consulting — money from companies marketing their products. This is the relationship to weigh against a recommendation. For this doctor it is substantial.

$2,781,939
Royalty / ownership

Income for a device or method the doctor invented or owns — large for some surgeons, and not a conflict over what to prescribe you.

This is well above what most doctors receive in promotional payments — a relationship worth being aware of when weighing a recommendation.

Largest paying companies

The companies that paid this doctor the most in 2024 — each company's full total (promotional + research + royalty), from CMS's separate by-company report, so these may not add up to the split above.

Arthrex, Inc. $2,833,846
Prime Surgical, LLC $1,072
Linvatec Corporation $781
Team 1, LLC $143
Smith+Nephew, Inc. $120

What the payments were for

Royalty or license $2,781,939Consulting fees $16,820Speaking / services (non-CE) $16,240Food & beverage $2,259Travel & lodging $1,093

What this is — and is not

This is the public record companies are required by law to report (the Sunshine Act). A disclosed payment is a financial relationship — it is not proof of wrongdoing, and not evidence that it changed your care. Many payments are entirely legitimate (research, royalties for inventions, education). The point is transparency: you get to know, and to ask. It is not a rating of Dr. Jeffrey Dugas.

Also available: structured data · plain text. Verify at CMS Open Payments (NPI 1912974734).